Outlook Wealth Advisors’s ResMed RMD Stock Holding History

Outlook Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$877K	Sell	3,907 -80	-2%	-$19.9K	0.21%	100
2025 Q4	$960K	Buy	3,987 +698	+21%	+$179K	0.22%	90
2025 Q3	$900K	Sell	3,289 -325	-9%	-$88.8K	0.22%	97
2025 Q2	$933K	Sell	3,614 -16	-0.4%	-$3.82K	0.24%	82
2025 Q1	$813K	Buy	3,630 +18	+0.5%	+$4.2K	0.23%	86
2024 Q4	$826K	Sell	3,612 -74	-2%	-$17.8K	0.24%	87
2024 Q3	$900K	Buy	3,686 +102	+3%	+$22.8K	0.26%	76
2024 Q2	$686K	Buy	+3,584	New	+$727K	0.21%	95
2020 Q1	–	Sell	-2,838	Closed	-$440K	–	179
2019 Q4	$440K	Buy	2,838 +654	+30%	+$94.3K	0.25%	74
2019 Q3	$295K	Buy	+2,184	New	+$286K	0.18%	135

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Outlook Wealth Advisors's RMD Position: Q1 2026 in Review

Outlook Wealth Advisors reduced its ResMed (RMD) stake by 2% in Q1 2026, selling an estimated $19.9K and leaving 3,907 shares worth $877K. The position accounts for 0.21% of the portfolio, ranked #100.

Outlook Wealth Advisors first reported a position in RMD in Q3 2019 and has held it in 10 quarters since. The position peaked at $960K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Outlook Wealth Advisors held 3,907 shares of ResMed worth $877K as of Q1 2026.
Outlook Wealth Advisors sold 80 ResMed shares in Q1 2026, an estimated $19.9K.
ResMed made up 0.21% of Outlook Wealth Advisors's portfolio in Q1 2026, its #100 holding.
Outlook Wealth Advisors first reported a position in ResMed in Q3 2019 and has held it in 10 quarters since.
Outlook Wealth Advisors's ResMed position peaked at $960K in Q4 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Outlook Wealth Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.